Exhibit 1
JOINT FILING AGREEMENT
In accordance with Rule 13d-1(k) (1) (iii) under the Securities
Exchange Act of 1934, as amended, the persons named below agree to the joint
filing on behalf of each of them of a Statement on Schedule 13G/A filed on
June 10, 2003 (including amendments thereto) with respect to the common stock
of Genome Therapeutics Corp.
This Joint Filing Agreement shall be filed as an Exhibit to such Statement.
Dated: June 10, 2003
Smithfield Fiduciary LLC
By: /s/ Xxxxxx Xxxxxxxxxx
-------------------------------------
Xxxxxx Xxxxxxxxxx, Director
Highbridge International LLC
By: /s/ Xxxxxx Xxxxxxxxxx
-------------------------------------
Xxxxxx Xxxxxxxxxx, Director
Highbridge Capital Corporation
By: /s/ Xxxxxx Xxxxxxxxxx
-------------------------------------
Xxxxxx Xxxxxxxxxx, Controller
Highbridge Capital Management, LLC
By: /s/ Xxxxxx X. Xxxxxxx
-------------------------------------
Xxxxxx X. Xxxxxxx, Managing Director
